Close Window

Digital Look Email A Friend

Renalytix test gets US FDA marketing authorisation

Published by Josh White on 30th June 2023

(Sharecast News) - Renalytix announced on Friday that the US Food and Drug Administration (FDA) had granted De Novo marketing authorisation for its 'KidneyIntelX.dkd' prognostic test.

URL: http://www.digitallook.com/dl/news/story/33610752/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.